However, Cipla was very clear it does not want to get into vaccine manufacturing. Sohini Das reports. IMAGE: Healthcare workers wearing PPE kits carry syringes towards a Covid-19......
Several firms are stepping up to help their workforce cope with soaring temperatures. IMAGE: Workers drink water as they take a break at a construction site on a hot summer day in New Delhi, May......
Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......
Kindly note the image has been posted only for representational purposes.Photograph: Kind courtesy Pixabay.com The Indian pharmaceutical industry's recent tryst with the US drug regulator......
However, before the Moderna and Pfizer messenger ribonucleic acid (or mRNA) vaccines come to India via this route, the legalities around the indemnity clause will have to be settled, reports Sohini......
Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with......
In 1935, when Khwaja Abdul Hamied set up Cipla in Central Mumbai to manufacture medicines in India, few could have predicted that in the next few decades the company would take on the world's......
Indian pharmaceutical companies may have units abroad as part of “distributed manufacturing” across various locations, according to industry veterans. Illustration: Uttam......
'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.' Photograph: Kind courtesy Mankind Pharma/Facebook.com Mankind Pharma,......
Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.......